Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dopamine key to learning likes and dislikes

05.11.2004


For those who have wondered why they like or dislike certain things, or how they decide what to order from a menu, a team of researchers at the University of Colorado at Boulder says it’s dopamine.



A CU-Boulder team studying Parkinson’s disease patients found strong evidence that dopamine in the brain plays a key role in how people implicitly learn to make choices that lead to good outcomes, while avoiding bad ones. The finding could help researchers understand more about how the brain works and could lead to a better understanding and treatment of brain disorders like schizophrenia, according to CU-Boulder psychology graduate student Michael Frank, who led the study.

A paper on the subject by Frank, CU-Boulder psychology Associate Professor Randall O’Reilly and Lauren Seeberger of the Colorado Neurological Institute’s Movement Disorders Center appears in the Nov. 5 issue of Science Express, an online version of Science magazine. Often people will get a "gut feeling" that allows them to make a choice depending on how often it was associated with positive outcomes in the past. But people with Parkinson’s disease often have difficulty making these kinds of choices, Frank said.


To understand why, they developed a computer model of the effects of Parkinson’s disease and the medications used to treat it in the brain. From this model they predicted that Parkinson’s patients would differ in their decision making depending on whether or not they were taking their medication, which they confirmed in a subsequent study.

They found that patients on their medication were overly influenced by positive outcomes, while those who were off their medication were more influenced by negative outcomes, according to Frank. "Because Parkinson’s disease is caused by lower levels of the brain chemical dopamine, and the medications increase concentrations of this chemical, these results provide strong evidence that dopamine levels play a critical role in developing our likes and dislikes," Frank said.

Much of what is known about the brain comes from studying diseases that affect it, according to O’Reilly. So to understand how healthy people learn from their decisions, it helps to determine the conditions where learning is degraded. "Studying Parkinson’s patients helps us to understand how healthy people learn, by showing us what’s going on under the hood," O’Reilly said. "It’s kind of like when your car makes a funny noise and you discover how the fan belt works. In this case we looked at a disease that has showed us more about dopamine’s role in the learning system of the brain."

Dopamine also plays a critical role in many other neurological conditions including attention deficit disorder, schizophrenia and drug addiction, so these findings may have broader implications, according to Frank. For example, by more precisely understanding the detailed effects of dopamine in the brain, drugs could be designed to more directly target beneficial actions, without as many unwanted side effects. "This research clearly showed that current Parkinson’s medications have undesirable side effects on learning and decision making," Frank said. Other researchers have documented a sudden onset of gambling episodes associated with patients taking these medications. These episodes may have been caused by the increased sensitivity to positive outcomes caused by the medications, together with an insensitivity to losses, he said. "When experiencing a loss, dopamine levels are normally low in the brain, and the medication may prevent this from happening," Frank said.

By exploring the effects of potential drugs on different brain areas and circuits, the computer model can be used to find drugs that restore dopamine balance without causing these or other side effects. Similar applications to ADD are also possible. Currently, ADD is treated with drugs such as Ritalin that cause more dopamine to remain available in the brain, but these drugs also may block certain forms of learning, causing unwanted side effects. "This work helps us understand how the brain learns from experience, and translates this learning into decisions, the kinds of decisions we make on a daily basis, often without much conscious thought," Frank said. "Understanding how this process works in detail may help in developing strategies to generally improve our learning and decision-making abilities."

Randall O’Reilly | EurekAlert!
Further information:
http://www.colorado.edu

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>